These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 31145528

  • 1. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 2. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR, Reid SJ.
    Adv Appl Microbiol; 2010 Jan; 72():63-87. PubMed ID: 20602988
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 6. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR.
    J Appl Microbiol; 2012 Aug; 113(2):418-28. PubMed ID: 22616725
    [Abstract] [Full Text] [Related]

  • 7. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
    Peck AB, Canales BK, Nguyen CQ.
    Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
    [Abstract] [Full Text] [Related]

  • 8. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL.
    ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709
    [Abstract] [Full Text] [Related]

  • 9. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA, Hatch M, Garrett TJ.
    Metabolomics; 2020 Nov 21; 16(12):122. PubMed ID: 33219444
    [Abstract] [Full Text] [Related]

  • 10. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M.
    BJU Int; 2009 Jan 21; 103(1):18-21. PubMed ID: 19021605
    [Abstract] [Full Text] [Related]

  • 11. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
    Jafari GA, Fotouhi Ardakani R, Akhavan Sepahi M, Nowroozi J, Soltanpour MS.
    Iran J Kidney Dis; 2021 May 21; 15(3):190-198. PubMed ID: 33994378
    [Abstract] [Full Text] [Related]

  • 12. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells.
    Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H.
    Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773
    [Abstract] [Full Text] [Related]

  • 13. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL, Moradi L, Paiste H, Wood KD, Assimos DG, Holmes RP, Nazzal L, Hatch M, Knight J.
    Appl Environ Microbiol; 2021 Aug 26; 87(18):e0054421. PubMed ID: 34190610
    [Abstract] [Full Text] [Related]

  • 14. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
    Gnanandarajah JS, Abrahante JE, Lulich JP, Murtaugh MP.
    Urol Res; 2012 Oct 26; 40(5):467-73. PubMed ID: 22223029
    [Abstract] [Full Text] [Related]

  • 15. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H.
    Urol Res; 2005 Nov 26; 33(5):372-5. PubMed ID: 16284877
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.
    Batislam E, Yilmaz E, Yuvanc E, Kisa O, Kisa U.
    Urol Res; 2012 Oct 26; 40(5):455-60. PubMed ID: 22215293
    [Abstract] [Full Text] [Related]

  • 17. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A.
    Postepy Hig Med Dosw (Online); 2013 Nov 27; 67():1144-53. PubMed ID: 24379255
    [Abstract] [Full Text] [Related]

  • 18. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.
    Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M.
    Med Princ Pract; 2003 Nov 27; 12(4):208-13. PubMed ID: 12966191
    [Abstract] [Full Text] [Related]

  • 19. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.
    Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS.
    Sci Rep; 2016 Oct 06; 6():34712. PubMed ID: 27708409
    [Abstract] [Full Text] [Related]

  • 20. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.
    Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR.
    J Am Soc Nephrol; 2008 Jun 06; 19(6):1197-203. PubMed ID: 18322162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.